Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Bayer
Age
12–65
Sex
MALE
Healthy volunteers
Not accepted
You may be eligible if
Male, aged 12 to 65 years
Severe hemophilia A defined as \< 1% FVIII:C
\>/= 150 days of previous treatment with FVIII in lifetime
Currently receiving on-demand or any type of prophylaxis treatment regimen with any FVIII product
No history of or current FVIII inhibitors
You may not be if
Presence of another bleeding disease that is different from hemophilia A (e.g., von Willebrand disease, hemophilia B)
Low platelet count, abnormal kidney function, or liver disease
Received treatment with immune suppressing drugs within the last 3 months prior or requires treatment during the study. (Some drugs for hepatitis C, Human immunodeficiency virus (HIV), and steroids are allowed)
Receiving or has received other experimental drugs within 3 months prior to study entry
Allergy to Factor VIII or hamsters or mouse protein
